These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8771732)

  • 21. [Stimulation of the suppressor activity in relation to hematopoietic cells in the mouse thymus as affected by pertussis vaccine].
    Sanin AV; Lapaeva IA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1986; (4):20-3. PubMed ID: 2939886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative pathomorphologic study of the toxic properties of a corpuscular pertussis vaccine and of a cell-free pertussis preparation].
    Grigor'eva LV; Ozeretskovskaia MN; Chigirinskiĭ AE; Koval'skaia SIa; Bazhanova IG
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Aug; (8):52-7. PubMed ID: 2555983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A comparative analysis of the effect of Bordetella pertussis preparations on a primary culture of murine peritoneal macrophages].
    Tiukavkina SIu; Moskalenko EP
    Mikrobiol Z; 1996; 58(2):58-63. PubMed ID: 8983523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acellular pertussis vaccine].
    Zakharova NS; Britsina MV; Mertsalova NU; Bazhanova IG; Ozeretskovskaia MN; Zaĭtsev EM; Poddubikov AV; Semenov BF
    Zh Mikrobiol Epidemiol Immunobiol; 2008; (1):35-41. PubMed ID: 18368750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An alternative temperature-based histamine-sensitisation test for absence of residual pertussis toxin in acellular pertussis vaccines.
    Jensen SE; Engelhart Illigen KE; Hasløv KR
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):73-4. PubMed ID: 20223192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of a safe, potent and immunogenic partially purified acellular pertussis vaccine using simple indigenous techniques.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Dev Biol Stand; 1991; 73():205-22. PubMed ID: 1778314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-Mediated and Humoral Immune Responses to Bordetella pertussis Inactivated Whole-Cells Encapsulated Alginate Microspheres as a New Vaccine Candidate.
    Dounighi NM; Shahcheraghi F; Razzaghi-Abyaneh M; Nofeli M; Zolfagharian H
    Curr Pharm Biotechnol; 2017; 18(7):585-593. PubMed ID: 28814229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative biological activities of acellular pertussis vaccines produced by Kitasato.
    Watanabe M; Izumiya K; Sato T; Yoshino K; Nakagawa N; Ohoishi M; Hoshino M
    Kitasato Arch Exp Med; 1991 Apr; 64(1):31-42. PubMed ID: 1798236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experimental induction by pertussis vaccine of nonspecific and specific T-suppressor cells inhibiting B-cell function].
    Prilepin NA; Semenov BF
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Sep; (9):91-6. PubMed ID: 6458188
    [No Abstract]   [Full Text] [Related]  

  • 30. Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen- to nineteen-month-old infants.
    Halperin SA; Davies HD; Barreto L; Guasparini R; Meekison W; Humphreys G; Eastwood BJ
    J Pediatr; 1997 Apr; 130(4):525-31. PubMed ID: 9108847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between mouse intracerebral potency & 50 per cent histamine sensitizing dose of pertussis vaccine.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    Indian J Med Res; 1989 May; 89():144-9. PubMed ID: 2476391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicity and potency evaluation of pertussis vaccines.
    Corbel MJ; Xing DK
    Expert Rev Vaccines; 2004 Feb; 3(1):89-101. PubMed ID: 14761246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two different histamine-sensitizing activities of pertussis vaccine observed in mice on the 4th and 12th days of sensitization.
    Horiuchi Y; Feng DJ; Kameyama S; Takahashi M; Asada S; Asakawa S; Ishida S
    Jpn J Med Sci Biol; 1993 Feb; 46(1):17-27. PubMed ID: 8230805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of glutaraldehyde inactivated pertussis vaccine.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Vaccine; 1990 Dec; 8(6):563-8. PubMed ID: 2128428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interrelation of the toxicity and capacity of pertussis vaccines to alter the body immune response to heterogenetic antigens].
    Levina LA; Elkina SI; Beĭlina VB; Prilepin NA; Kalina NG
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Jan; (1):75-9. PubMed ID: 6282013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of toxicities of acellular pertussis vaccine with whole cell pertussis vaccine in experimental animals.
    Sato Y; Sato H
    Dev Biol Stand; 1991; 73():251-62. PubMed ID: 1778317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roads to the development of improved pertussis vaccines paved by immunology.
    Brummelman J; Wilk MM; Han WG; van Els CA; Mills KH
    Pathog Dis; 2015 Nov; 73(8):ftv067. PubMed ID: 26347400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the optimal conditions for inactivation of Bordetella pertussis organisms with glutaraldehyde for preparation of a safe and potent pertussis vaccine.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Vaccine; 1988 Dec; 6(6):491-6. PubMed ID: 2907704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and detoxification of an easily prepared acellular pertussis vaccine. Antigenic role of the A protomer of pertussis toxin.
    García-Sáinz JA; Romero-Avila MT; Ruíz-Arriaga A; Ruíz-Puente J; Agundis C; Ortiz V; Isibasi A
    Vaccine; 1992; 10(5):341-4. PubMed ID: 1574919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunogenicity and toxicity of soluble trichloroacetic acid precipitate from pertussis microbes and its fractions].
    Bazhanova IG; Gladkaia VI; Liashenko VA
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Nov; (11):128-32. PubMed ID: 202117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.